Robinhood Ventures Fund II (RVII): What the 80-Startup BDC Owns, Costs, and Risks

Robinhood Ventures Fund II gives public-market investors access to a venture portfolio centered on early- and growth-stage companies, many connected to Y Combinator. The pitch is powerful: buy one NYSE-listed security and participate in a broad group of private startups without accredited-investor status or a decade-long venture-fund lockup.

The structure is more complicated than the pitch.

RVII is not an ETF. It is a diversified closed-end management investment company that elected business development company, or BDC, status. Its shares trade on the New York Stock Exchange, but shareholders cannot redeem them at NAV. The adviser charges a 2% base management fee and can receive a 20% incentive fee on cumulative realized capital gains after specified losses and depreciation. The final prospectus estimated total annual expenses of 4.08% before any material incentive fee or borrowing costs.

My view: RVII is an innovative access vehicle with genuine upside if its startup portfolio produces a few extraordinary winners. It is also a speculative, fee-heavy, hard-to-value fund run by a new adviser. The correct question is not whether the venture theme sounds exciting. It is whether future portfolio value can overcome failures, expenses, dilution, valuation uncertainty, and a market price that may never equal NAV.

Robinhood announced RVII on August 3, priced 8 million IPO shares at $25 on August 13, and later reported that those shares were issued and outstanding after the offering. The NYSE listing and Robinhood’s post-settlement share-count notice confirm this is a completed public listing, not a planned product.

The fund is a Delaware statutory trust with a perpetual term. It is externally managed by Robinhood Ventures DE, a Robinhood Markets subsidiary and SEC-registered investment adviser formed in August 2025. The prospectus explicitly says the adviser has limited investing history and no previous experience managing a BDC.

That matters because venture selection, follow-on decisions, fair-value marks, conflicts, and exit timing all depend on the manager. A famous distribution platform does not remove manager risk.

BDC status also does not make RVII a normal dividend stock. The stated objective is long-term capital appreciation. The fund says it does not anticipate predictable quarterly dividends. If it produces earnings or realized gains, it intends to make at least annual distributions subject to board action and applicable rules. Investors looking for the regular income associated with many mature lending BDCs are looking at the wrong product.

The final prospectus’s unaudited July 31 schedule listed 80 portfolio companies. Most were represented by $250,000 simple agreements for future equity, commonly called SAFEs. A SAFE is not ordinary common stock. It is a contract designed to convert into equity after a future financing or another specified event, subject to its own terms.

The portfolio includes companies across artificial intelligence, software, financial technology, robotics, healthcare, semiconductors, aerospace, defense, energy, and consumer products. Robinhood’s strategy emphasizes current or former Y Combinator participants and companies whose founders participated in the program, although the fund can invest outside that network.

This is a different exposure from RVI. RVI is concentrated in a short list of later-stage and high-profile companies. RVII spreads capital across a much larger group of earlier businesses. The expected return pattern is therefore different: many investments may fail or remain small, while a few winners must create a disproportionate share of the value.

The final filing listed 80 companies, while a Robinhood product graphic has displayed 81 holdings using an earlier July 15 date. Those numbers should not be treated as a contradiction without checking position-level details. A fund can have more holdings than operating companies because separate securities, share classes, or vehicles may be counted independently. The final prospectus is the stronger source for the number of portfolio companies at the IPO.

Y Combinator permits RVII to use its name under an agreement, but it does not sponsor, endorse, or manage the fund. That distinction belongs near the top of any honest analysis. A connection to the YC ecosystem may improve sourcing; it is not a guarantee that YC stands behind the product or that the companies will succeed.

Most RVII positions were young, illiquid securities without active market prices. The prospectus reported many SAFEs at cost or estimated fair value. Those marks can stay unchanged until a financing round, conversion, impairment, or other event produces new evidence.

That creates several layers of uncertainty. A startup can run out of money before the SAFE converts. A later financing can occur at worse terms. New investors can receive senior rights. A headline valuation can obscure dilution or liquidation preferences. Even when a company grows, the fund may wait years before it can sell anything.

The power-law math of venture investing is real: one exceptional winner can repay many losses. The reverse is also true. A large collection of startup names is not automatically diversified in the way a total-market index is. Many companies can share the same exposure to AI spending, venture financing conditions, interest rates, talent costs, and exit markets.

The fund may also invest indirectly through special-purpose vehicles, private funds, and other vehicles. Those structures can add capital calls, extra fees, limited transparency, or holdings that are harder to map.

RVII sold 8 million shares at $25, creating $200 million of gross IPO proceeds. Robinhood described a $225.5 million total fund size before the sales load and offering expenses, including capital already in the vehicle. That number should not be called IPO proceeds.

The final prospectus estimated net offering proceeds of approximately $185.1 million after the underwriting load and organizational and offering costs, or $213.7 million if the full underwriter option were exercised. As of August 27, the official share-count notice said the company would update investors by September 11 if the option changed the outstanding-share count. I would not assume it was exercised without that update.

The offering carried a 4.5% sales load, equal to $1.125 per IPO share. Estimated offering expenses borne by the fund were another 2.12%, or about $4.2 million, and organizational-cost reimbursement to Robinhood further reduced assets. Those were IPO economics, not a new commission automatically charged to someone buying shares later on the exchange. They still matter because costs paid by the fund reduce the NAV supporting all shares.

This is why a market price below the $25 IPO price is not automatically a discount to NAV. IPO price and NAV are different numbers. Until RVII publishes a reliable post-offering NAV, the honest comparison is “above or below the IPO price,” not “above or below NAV.”

The marketed 2% base management fee is only one line.

The final prospectus estimated annual expenses of 4.08% for the first fiscal year based on the original 8 million IPO shares. That estimate included the 2.00% base management fee, 1.97% of other expenses, and 0.11% of acquired-fund fees and expenses. The other-expense estimate included 0.80% for repayment to Robinhood and 1.17% for other costs.

The 4.08% estimate excluded any material capital-gains incentive fee and borrowing interest. The adviser can earn 20% of cumulative realized capital gains, net of cumulative realized losses and unrealized depreciation, less incentive fees previously paid. The fee table showed no first-year estimate for that line; the dash did not mean the incentive fee was waived.

The prospectus’s standardized example estimated that a hypothetical $1,000 investment earning 5% annually would bear $84 of expenses in year one, $164 over three years, $245 over five years, and $453 over ten years. That illustration is not a forecast, but it makes the hurdle visible.

High costs do not prove the fund will perform poorly. Venture sourcing, legal work, due diligence, valuations, administration, and private transactions are expensive. The correct takeaway is that gross portfolio gains and shareholder returns can be very different. The manager must create substantial value before the investor keeps an attractive result.

RVII expected to invest substantially all net proceeds within approximately 36 months. Until then, uninvested capital can sit in listed securities, funds, government or fixed-income instruments, cash equivalents, or even permitted digital assets.

This creates a pacing problem. Move too slowly, and cash plus expenses can drag results. Move too quickly, and the manager may sacrifice selectivity just to deploy capital. Follow-on financing creates another decision: defend ownership in the strongest companies or reserve cash for new opportunities.

The portfolio shown at the IPO represented roughly $20 million of startup investments before the much larger offering proceeds were fully deployed. Therefore, the 80-company list was the starting portfolio, not necessarily a picture of where most post-IPO net assets would remain. Investors need future 10-Q and 10-K filings to see actual allocation, new positions, follow-ons, cash, marks, and realized results.

RVII shares trade during the day, but the underlying investments may take years to monetize. The fund does not offer shareholder redemption at NAV. If sellers outnumber buyers, the market price can remain below NAV even if the private portfolio is unchanged. If enthusiasm becomes extreme, the shares can trade above NAV and expose buyers to a later premium collapse.

Exchange listing solves the investor lockup problem by transferring liquidity risk into the market price. It does not make the underlying SAFEs liquid.

RVII can also use leverage within BDC limits. The prospectus did not anticipate material borrowing costs in the initial fiscal-year estimate, but future leverage could magnify gains, losses, and expenses. That is another line to check in every filing.

Robinhood affiliates can earn more from RVII than from unaffiliated products. The adviser may face decisions about allocating attractive investments between RVI, RVII, future funds, or related vehicles. It also participates in valuing securities that determine reported NAV and affect management-fee calculations.

These conflicts are disclosed, not hidden, but disclosure does not make them irrelevant. Investors should watch valuation policies, related-party transactions, expense reimbursements, cross-fund allocations, and board oversight.

The adviser’s limited history is equally important. The relevant scoreboard will be future marks validated by financing rounds and exits—not the number of companies added or the strength of the marketing narrative.

RVII does not need most of its companies to become giant winners. It needs enough outliers to offset failures, fees, dilution, and the time value of money. A successful pattern would include higher-quality follow-on rounds, improving fair values backed by third-party transactions, disciplined new deployment, several liquidity events, and a market price that does not remain permanently detached from NAV.

Failure would look different: repeated write-downs, rushed deployment, layered fees, weak follow-on access, few exits, leverage introduced before the portfolio matures, or a persistent discount that shareholders cannot escape through redemption.

RVII is a venture portfolio wrapped in a public security, not an ETF with daily portfolio transparency and a redemption mechanism. The public wrapper makes it easy to buy and sell. It does not remove the private-market risks underneath.

The attraction is clear: broad access to early-stage companies, a sourcing strategy tied to the YC ecosystem, and the possibility that a few exceptional winners drive long-term appreciation. The tradeoffs are equally clear: startup failure, uncertain SAFE valuations, years-long exits, a new adviser, conflicts, no predictable income, no redemption at NAV, and a first-year expense estimate of 4.08% before any material performance fee or interest cost.

RVII may become a useful venture sleeve for investors who understand those tradeoffs. It should not be presented as a cheap or simple ETF. The real test begins after the IPO, when Robinhood must turn access into realized value after all expenses.

This article is general education and market research only. It is not personalized investment advice or a recommendation to buy, sell, short, or hold RVII or any underlying company. Startup investments can fail, valuations can change materially, and fund shares can trade far above or below NAV. Verify the latest filings and market quote before risking money.